BCL2 and Parkinson disease: A previous study focused on the relationship between the phosphorylation of Bcl-2 at Thr56 and leucine-rich repeat kinase 2 (LRRK2), a relationship that may be associated with Parkinson’s disease and melanoma [31,33,34].